|
J Biol Chem, Vol. 274, Issue 52, 37131-37138, December 24, 1999
Transcriptional Anti-repression
THYROID HORMONE RECEPTOR -2 RECRUITS SMRT COREPRESSOR BUT
INTERFERES WITH SUBSEQUENT ASSEMBLY OF A FUNCTIONAL COREPRESSOR
COMPLEX*
Zhihong
Yang ,
Suk-Hyun
Hong, and
Martin L.
Privalsky§
From the Section of Microbiology, Division of Biological Sciences,
University of California, Davis, California 95616
Thyroid hormone receptors (T3Rs) are
hormone-regulated transcription factors. Different T3R isoforms are
expressed in a tissue-specific and developmentally regulated manner.
The T3R -1, -0, and -1 isoforms typically repress target gene
expression in the absence of hormone and activate transcription in the
presence of hormone. Intriguingly, however, the T3R -2 isoform fails
to repress, and instead is able to activate transcription in both the
absence and presence of hormone. We investigated the molecular
mechanism behind this absence of repression by T3R -2. Repression by
T3R -1, -0, and -1 is mediated by the ability of these isoforms
to physically recruit a SMRT/N-CoR corepressor complex. We determined
that the unliganded T3R -2 also recruits the SMRT corepressor; in
contrast to the -1, -0, and -1 isoforms, however, the T3R -2
protein interacts not only with the C-terminal "receptor-interaction
domain" of SMRT, but also makes additional contacts with the
N-terminal "silencing domain" of the SMRT corepressor. These
additional, T3R -2-specific contacts interfere with the subsequent
association of SMRT with mSin3, a crucial second subunit of the
corepressor holo-complex. Our results suggest that T3R -2 regulates
transcription through a novel anti-repression mechanism, recruiting
SMRT, but preventing the subsequent formation of a functional
corepressor complex.
*
This work was supported in part by Public Health
Services/National Institutes of Health Grants R37 CA-53394 and R01
DK-53528.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported in part by a University of California-Davis
biotechnology fellowship.
§
To whom correspondence should be addressed. Tel.: 530-752-3013;
Fax: 530-752-9014; E-mail: mlprivalsky@ucdavis.edu.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. L. Privalsky, S. Lee, J. B. Hahm, B. M. Young, R. N. G. Fong, and I. H. Chan
The p160 Coactivator PAS-B Motif Stabilizes Nuclear Receptor Binding and Contributes to Isoform-specific Regulation by Thyroid Hormone Receptors
J. Biol. Chem.,
July 17, 2009;
284(29):
19554 - 19563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. W. O'Malley and N. J. McKenna
Editorial: Coactivators and Corepressors: What's in a Name?
Mol. Endocrinol.,
October 1, 2008;
22(10):
2213 - 2214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tian, M. A. Mahajan, C. T. Wong, I. Habeos, and H. H. Samuels
The N-Terminal A/B Domain of the Thyroid Hormone Receptor-{beta}2 Isoform Influences Ligand-Dependent Recruitment of Coactivators to the Ligand-Binding Domain
Mol. Endocrinol.,
September 1, 2006;
20(9):
2036 - 2051.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-B. Poirier, G. Hamann, M.-E. Domingue, M. Roy, T. Bardati, and M.-F. Langlois
General Receptor for Phosphoinositides 1, a Novel Repressor of Thyroid Hormone Receptor Action that Prevents Deoxyribonucleic Acid Binding
Mol. Endocrinol.,
August 1, 2005;
19(8):
1991 - 2005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Wan, B. Farboud, and M. L. Privalsky
Pituitary Resistance to Thyroid Hormone Syndrome Is Associated with T3 Receptor Mutants that Selectively Impair {beta}2 Isoform Function
Mol. Endocrinol.,
June 1, 2005;
19(6):
1529 - 1542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Mengeling, F. Pan, and M. L. Privalsky
Novel Mode of Deoxyribonucleic Acid Recognition by Thyroid Hormone Receptors: Thyroid Hormone Receptor {beta}-Isoforms Can Bind as Trimers to Natural Response Elements Comprised of Reiterated Half-Sites
Mol. Endocrinol.,
January 1, 2005;
19(1):
35 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Cote, S. McNamara, D. Brambilla, A. Bianchini, G. Rizzo, S. V. del Rincon, F. Grignani, C. Nervi, and W. H. Miller Jr
Expression of SMRT{beta} promotes ligand-induced activation of mutated and wild-type retinoid receptors
Blood,
December 15, 2004;
104(13):
4226 - 4235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Farboud and M. L. Privalsky
Retinoic Acid Receptor-{alpha} Is Stabilized in a Repressive State by Its C-Terminal, Isotype-Specific F Domain
Mol. Endocrinol.,
December 1, 2004;
18(12):
2839 - 2853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Torres-Padilla, F. M. Sladek, and M. C. Weiss
Developmentally Regulated N-terminal Variants of the Nuclear Receptor Hepatocyte Nuclear Factor 4alpha Mediate Multiple Interactions through Coactivator and Corepressor-Histone Deacetylase Complexes
J. Biol. Chem.,
November 15, 2002;
277(47):
44677 - 44687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Guissouma, S. M. Dupre, N. Becker, E. Jeannin, I. Seugnet, B. Desvergne, and B. A. Demeneix
Feedback on Hypothalamic TRH Transcription Is Dependent on Thyroid Hormone Receptor N Terminus
Mol. Endocrinol.,
July 1, 2002;
16(7):
1652 - 1666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Marimuthu, W. Feng, T. Tagami, H. Nguyen, J. L. Jameson, R. J. Fletterick, J. D. Baxter, and B. L. West
TR Surfaces and Conformations Required to Bind Nuclear Receptor Corepressor
Mol. Endocrinol.,
February 1, 2002;
16(2):
271 - 286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Becker, I. Seugnet, H. Guissouma, S. M. Dupre, and B. A. Demeneix
Nuclear Corepressor and Silencing Mediator of Retinoic and Thyroid Hormone Receptors Corepressor Expression Is Incompatible with T3-Dependent TRH Regulation
Endocrinology,
December 1, 2001;
142(12):
5321 - 5331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Yang and M. L. Privalsky
Isoform-Specific Transcriptional Regulation by Thyroid Hormone Receptors: Hormone-Independent Activation Operates through a Steroid Receptor Mode of Coactivator Interaction
Mol. Endocrinol.,
July 1, 2001;
15(7):
1170 - 1185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Yen
Physiological and Molecular Basis of Thyroid Hormone Action
Physiol Rev,
July 1, 2001;
81(3):
1097 - 1142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Williams
Cloning and Characterization of Two Novel Thyroid Hormone Receptor beta Isoforms
Mol. Cell. Biol.,
November 15, 2000;
20(22):
8329 - 8342.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Guerardel, S. Deltour, S. Pinte, D. Monte, A. Begue, A. K. Godwin, and D. Leprince
Identification in the Human Candidate Tumor Suppressor Gene HIC-1 of a New Major Alternative TATA-less Promoter Positively Regulated by p53
J. Biol. Chem.,
January 26, 2001;
276(5):
3078 - 3089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-N. Song, B. Huse, S. Rusconi, and S. S. Simons Jr.
Transactivation Specificity of Glucocorticoid Versus Progesterone Receptors. ROLE OF FUNCTIONALLY DIFFERENT INTERACTIONS OF TRANSCRIPTION FACTORS WITH AMINO- AND CARBOXYL-TERMINAL RECEPTOR DOMAINS
J. Biol. Chem.,
June 29, 2001;
276(27):
24806 - 24816.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|